# Anicare Pharmaceuticals Pvt Ltd. – FDA Inspection, Aug 3, 2018

Source: https://www.keypedia.com/records/fda_inspections/anicare-pharmaceuticals-pvt-ltd/530ba2e2-557c-49b1-b242-3a199c99afb1
Source feed: FDA_Inspections

> FDA inspection 1061011 of Anicare Pharmaceuticals Pvt Ltd., August 03, 2018. Classification: Official Action Indicated (OAI). 9 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061011
- Company Name: Anicare Pharmaceuticals Pvt Ltd.
- Inspection Date: 2018-08-03
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 9
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1195342 - 2023-01-20](https://www.keypedia.com/records/fda_inspections/anicare-pharmaceuticals-pvt-ltd/8abf3923-4f0b-4ad4-9720-6feda23b7fa1)
- FDA Inspection 978860 - 2016-07-14

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/liming-zhang/6c93b721-8725-4d87-8a42-254f3de5e49d)

Company: https://www.keypedia.com/companies/anicare-pharmaceuticals-pvt-ltd/27a62bcb-3beb-47a7-9f76-acc526f0388f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c